Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma Group (MREO) Intangibles: 2020-2024

Historic Intangibles for Mereo BioPharma Group (MREO) over the last 4 years, with Dec 2024 value amounting to $643,000.

  • Mereo BioPharma Group's Intangibles fell 19.52% to $643,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $643,000, marking a year-over-year decrease of 19.52%. This contributed to the annual value of $643,000 for FY2024, which is 40.96% down from last year.
  • Mereo BioPharma Group's Intangibles amounted to $643,000 in FY2024, which was down 40.96% from $1.1 million recorded in FY2023.
  • In the past 5 years, Mereo BioPharma Group's Intangibles registered a high of $42.4 million during FY2020, and its lowest value of $643,000 during FY2024.
  • Over the past 2 years, Mereo BioPharma Group's median Intangibles value was $866,000 (recorded in 2023), while the average stood at $866,000.
  • Data for Mereo BioPharma Group's Intangibles shows a maximum YoY plummeted of 40.96% (in 2024) over the last 5 years.
  • Over the past 4 years, Mereo BioPharma Group's Intangibles (Yearly) stood at $42.4 million in 2020, then decreased by 21.87% to $33.1 million in 2021, then reached $1.1 million in 2023, then crashed by 40.96% to $643,000 in 2024.